原型抗反刍动物衣原体重组蛋白疫苗在羔羊和妊娠母羊中的安全性与免疫原性
研究测试了由主要外膜蛋白(MOMP-G)和多形膜蛋白G(PmpG)组成的原型反刍动物衣原体疫苗(SC疫苗)在羔羊和妊娠母羊中的安全性与免疫原性。所有动物对单次和两次注射耐受良好;母羊整体免疫应答较差,但其羔羊的抗原特异性免疫应答强于对照疫苗母羊所产羔羊;羔羊接种可诱导全身抗MOMP-G和抗PmpG IgG及眼黏膜分泌型IgA,两次接种使体液应答高度和持续时间出现统计学显著增加。
要点
- SC疫苗单次和两次注射在所有母羊和羔羊中耐受良好。
- 妊娠母羊整体免疫应答较差,但其羔羊抗原特异性免疫应答强于对照疫苗母羊所产羔羊。
- 羔羊接种触发全身抗MOMP-G和抗PmpG IgG及眼黏膜分泌型IgA,并产生抗原特异性IFN-γ。
核心结论
- 原型SC疫苗在羔羊和妊娠母羊中耐受良好,羔羊接种可诱导抗原特异性体液和细胞免疫应答。
研究设计与样本
- 在羔羊和妊娠母羊中测试原型反刍动物衣原体疫苗(SC疫苗),该疫苗由MOMP-G和PmpG组成。
主要发现
- 所有母羊和羔羊对SC疫苗单次和两次注射均耐受良好。
- 母羊对SC疫苗接种的整体免疫应答较差,但其羔羊的抗原特异性免疫应答强于对照疫苗母羊所产羔羊。
- 羔羊接种SC疫苗触发全身抗MOMP-G和抗PmpG IgG抗体以及眼黏膜分泌型IgA的产生。
- 两次接种使体液应答的高度和持续时间出现统计学显著增加。
- 接种羔羊的外周血单核细胞产生抗原特异性IFN-γ。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Arthritis and kerato-conjunctivitis caused by Chlamydia pecorum in lambs are difficult to diagnose and treat. We tested the ability of a prototype C. pecorum vaccine (SC-vaccine), comprised of C. pecorum major outer membrane protein (MOMP-G) and polymorphic membrane protein G (PmpG), to trigger a Chlamydia-specific humoral and cell-mediated immune response in lambs and pregnant ewes. Vaccinations with the SC-vaccine (one and two injections) were very well tolerated by all ewes and lambs. Although the overall immune responses of ewes to SC-vaccination was poor, their lambs showed stronger antigen-specific immune response than lambs from control vaccine ewes. SC-vaccination in lambs triggered production of systemic anti-MOMP-G and anti-PmpG IgG antibodies and secretory IgA in the ocular mucosa. Double vaccination caused statistically significant increases in the height and duration of the humoral response. Antigen-specific IFN-γ was produced in the peripheral blood mononuclear cells of vaccinated lambs.
引用
- Desclozeaux M, Jelocnik M, Whitting K, et al. Safety and immunogenicity of a prototype anti-Chlamydia pecorum recombinant protein vaccine in lambs and pregnant ewes. Vaccine. 2017. PMID: 28528762. doi:10.1016/j.vaccine.2017.03.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。